BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heller M, Parikh ND, Fidelman N, Owen D. Frontiers of therapy for hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3648-59. [PMID: 33837453 DOI: 10.1007/s00261-021-03065-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Yuan X, Yang Y, Wanyan Y, Tao L, Chen Y. Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model. Cell Adh Migr 2023;17:20-34. [PMID: 36656313 DOI: 10.1080/19336918.2023.2168231] [Reference Citation Analysis]
2 Zhou M, Zhu S, Xu C, Liu B, Shen J. A multicenter, open-label, multiple-dose Phase Ib/II study evaluating the safety and tolerability of CS3008 (BLU-554) in combination with CS1001 in subjects with locally advanced or metastatic hepatocellular carcinoma (HCC) Research.. [DOI: 10.21203/rs.3.rs-2268063/v2] [Reference Citation Analysis]
3 Wu D, Cai Q, Liu D, Zuo G, Li S, Liu L, Zheng J. Identification of molecular subtypes and prognostic signatures based on transient receptor potential channel-related genes to predict the prognostic risk of hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2177604/v1] [Reference Citation Analysis]
4 Chen X, Hu G, Xiong L, Xu Q. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma. Pathol Oncol Res 2022;28:1610558. [DOI: 10.3389/pore.2022.1610558] [Reference Citation Analysis]
5 Liao W, Shi Z, Tang H, Wu T, Zhang C, He Y, Zou R, Wang L, Zhang Z. Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/6851026] [Reference Citation Analysis]
6 Orrapin S, Udomruk S, Lapisatepun W, Moonmuang S, Phanphaisarn A, Phinyo P, Pruksakorn D, Chaiyawat P. Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review. Cancers 2022;14:3373. [DOI: 10.3390/cancers14143373] [Reference Citation Analysis]